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Coenzyme Q10 (CoQ) is a small lipophilic molecule critical 
for the transport of electrons from complexes I and II to complex 
III in the mitochondrial respiratory chain. CoQ deficiency is a 
rare human genetic condition that has been associated with a 
variety of clinical phenotypes. With the aim of elucidating how 
CoQ deficiency affects an organism, we have investigated the 
pathophysiologic processes present within fibroblasts derived from 
four patients with CoQ deficiency. Assays of cultured fibroblasts 
revealed decreased activities of complex II + III, complex III 
and complex IV, reduced expression of mitochondrial proteins 
involved in oxidative phosphorylation, decreased mitochondrial 
membrane potential, increased production of reactive oxygen 
species (ROS), activation of mitochondrial permeability transi-
tion (MPT), and reduced growth rates. These abnormalities were 
partially restored by CoQ supplementation. Moreover, we demon-
strate that CoQ-deficient fibroblasts exhibited increased levels 
of lysosomal markers (β-galactosidase, cathepsin, LC3 and Lyso 
Tracker), and enhanced expression of autophagic genes at both 
transcriptional and translational levels, indicating the presence 
of autophagy. Electron microscopy studies confirmed a massive 
degradation of the altered mitochondria by mitophagy. Autophagy 
in CoQ-deficient fibroblasts was abolished by antioxidants or 
cyclosporin treatments suggesting that both ROS and MPT partici-
pate in this process. Furthermore, prevention of autophagy in 
CoQ-deficient fibroblasts by 3-methyl adenine or wortmannin, as 
well as the induction of CoQ deficiency in cells lacking autophagy 
(by means of genetic knockout of the Atg5 gene in mouse embry-
onic fibroblasts) resulted in apoptotic cell death, suggesting a 
protective role of autophagy in CoQ deficiency.
Introduction
Coenzyme Q10 (CoQ) is an essential electron and proton carrier 
in the mitochondrial respiratory chain (MRC), transferring electrons 
from complexes I and II to complex III,1 and contributing to the 
ATP biosynthesis. Furthermore, CoQ is essential for the stability of 
complex III in the mitochondrial respiratory chain,2 functions as an 
antioxidant in cell membranes,3 and is involved in multiple aspects 
of cellular metabolism. CoQ is also required for pyrimidine nucleo-
side biosynthesis and may modulate apoptosis and mitochondrial 
uncoupling proteins.4 CoQ is composed of a benzoquinone ring, 
synthesized from tyrosine, and a polyprenyl side-chain, generated 
from acetyl-CoA through the mevalonate pathway.5 In eukaryotes, 
the biosynthesis of CoQ is a very complex process involving at least 
ten genes (COQ genes).6 Mutations in these genes cause primary 
CoQ deficiency,7 a severe and often fatal multisystem disorder. 
However affected patients respond well to oral CoQ supplementa-
tion. To date, mutations have been identified in COQ2, PDSS1 and 
PDSS2 genes.
The first COQ2 mutation was found in two patients with 
encephalomyopathy and nephropathy.8,9 This gene encodes the 
para-hydroxybenzoate-polyprenyltransferase that condensates the 
4-OH benzoate ring with the prenyl side chain. Mutations in the 
PDSS2 gene, encoding the small subunit of prenyldisphosphate 
synthase, have also been reported in a patient with Leigh syndrome 
and nephropathy,10 as well as a homozygous PDSS1 misssense muta-
tion in two patients with a less severe multisystem disease.11 Some 
patients with cerebellar ataxia or isolated myopathies have secondary 
CoQ deficiencies due to mutations in APTX and ETFDH, genes not 
directly related to ubiquinone synthesis.12-15
The hallmark of CoQ-deficiency syndrome is a decrease in CoQ 
levels in muscle and/or fibroblasts. Patients exhibit variable degrees 
of CoQ deficiency in muscle and/or fibroblasts causing decrease 
of CoQ-dependent MRC activities, such as NADH:citochrome 
c oxidoreductase (complex I + III) and succinate:citochrome c 
oxidoreductase (complex II + III). However, the effects of CoQ 
deficiency on other MRC aspects, such as ATP synthesis, oxygen 
consumption, and mitochondrial membrane potential measurements 
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measured the activities of respiratory enzymes in control and patient 
fibroblasts (Fig. 1). As expected, patient fibroblasts showed a signifi-
cant reduction in the activity of those mitochondrial respiratory 
enzymes whose activities depend directly on CoQ (complex III and 
complex II + III). In addition, the activity of complex IV was also 
significantly decreased (Fig. 1). In contrast the activity of complex I 
was not significantly different from control values.
To further examine mitochondrial dysfunction in CoQ-deficient 
cells, we compared the expression of mitochondrial proteins in control 
and patient fibroblasts by western blotting. As shown in Figure 2A, 
the expression of mitochondrial protein subunits of complexes III 
(core I subunit), and IV (COX II subunit) was reduced in patient 
fibroblasts, correlating with their reduced enzyme activities.
To verify that these alterations were directly related to CoQ defi-
ciency, we treated fibroblasts with CoQ for 72 hours and checked for 
the recovery of mitochondrial functionality. As is shown in Figure 1, 
enzyme activities were significantly restored following CoQ supple-
mentation. As CoQ is a component of complex III and is required to 
its stability, proteins from this complex were analyzed (Fig. 2B). CoQ 
restored partially the composition of complex III.
Mitochondrial membrane potential in CoQ deficiency. To assess 
the functional consequences of reduced respiratory enzyme activities 
and protein levels in mitochondria in CoQ deficiency, we deter-
mined mitochondrial membrane potential (ΔΨm) in both control 
and patient fibroblasts by flow cytometry and fluorescence micros-
copy. As shown in Figure 3A, patient fibroblasts showed a significant 
reduction in ΔΨm indicating a lower capacity to produce ATP in 
CoQ deficient fibroblasts.
ROS production in CoQ deficiency. It is well known that 
mitochondrial dysfunction is associated with an induction of ROS 
production in mitochondria. Therefore, we examined ROS levels in 
control and patient fibroblasts by flow cytometry using the dichloro-
dihydrofluorescein probe. Figure 3B shows an increased production 
of ROS in patient fibroblasts compared to control. We also confirmed 
that CoQ supplementation significantly reduced ROS production.
Mitocondrial permeability transition (MPT) pore in CoQ 
deficiency. As a major source of ROS production, mitochondria 
are especially prone to ROS damage. Such damage can induce 
the mitochondrial permeability transition (MPT) caused by the 
opening of nonspecific high conductance permeability transi-
tion pores in the mitochondrial inner membrane.25 To investigate 
whether CoQ deficiency can induce MPT in patient fibroblasts, we 
employed the acetoxymethyl (AM) ester of calcein, and CoCl2, a 
have scarcely been reported. Some authors have reported decreases 
in oxygen consumption (state-3 respiration) in muscle mitochon-
dria for several substrates except ascorbate/TMDP,16,17 suggesting 
a CoQ-level dependent impairment of oxidative phosphorylation. 
A reduction in the mitochondrial membrane potential of cultured 
fibroblasts from patients with CoQ deficiency has also been demon-
strated.18,19 These findings suggest that dysfunctional oxidative 
phosphorylation may be an important factor in CoQ deficiency 
syndromes. There have been few reports regarding antioxidant status 
and oxidative stress in CoQ deficiency, and even these few have 
yielded conflicting results.20-22 In some studies, no signs of oxidative 
stress could be found in CoQ-depleted fibroblasts,23,24 yet in another 
study, CoQ-deficient fibroblasts incubation with dihydrorodamine 
(a marker of hydrogen peroxide production) showed a two-fold 
increase in fluorescence compared with control values.18 In light 
of these observations, a more exhaustive and complete assessment 
of the role of oxidative stress in CoQ deficiency syndrome, appears 
necessary. In addition, studies examining cell death, in the context of 
CoQ deficiency, have also been limited and somewhat contradictory. 
While an increase in apoptotic features has consistently been demon-
strated in muscle biopsies of CoQ-deficient patients,21 no evidence 
of apoptosis could be established in fibroblasts of CoQ-deficient 
patients in another study.20 Therefore, changes in cell death (apop-
tosis or autophagy), that are closely related to increased free radical 
damage, merit further investigation with respect to CoQ deficiency 
syndromes.
Here we aim to assess the pathophysiology of this disease in 
cultured fibroblasts derived from four patients with an oxidative 
phosphorylation defect associated with CoQ deficiency.
Results
Biochemical characterization of fibroblasts derived from four 
patients with CoQ deficiency. First, we confirmed that fibroblasts 
derived from the patients were deficient for CoQ. Fibroblast analysis 
results are reported in Table 1. All four cases showed clearly decreased 
CoQ levels, and a lower rate of CoQ biosynthesis with respect to 
control fibroblasts. The reduced growth rate of patients was restored 
by CoQ supplementation.
Mitochondrial dysfunction in CoQ deficiency. As CoQ is an 
essential component of the mitochondrial respiratory chain, the 
reduced levels of CoQ in fibroblast would be expected to induce an 
alteration in the normal mitochondrial electron flow. To determine 
the presence of mitochondrial dysfunction in CoQ deficient cells, we 
Table 1  Biochemical analysis of CoQ levels, incorporation of radiolabeled substrate to CoQ, and fibroblast growth 
after CoQ supplementation (100 µM) in cultured skin fibroblasts from 4 patients with a CoQ deficiency  
syndrome
Patient CoQ (nmol/g protein) 14C-p-hydroxybenzoate Fibroblast growth upon CoQ supplementation 
  (cpm x 106/mg protein) (1 week) (% increase in growth rate)
Case 1 44 (3.20) 22% of control 96%
Case 2 64 (3.90) 26% of controls 87%
Case 3 37 (2.17) 15% of controls 32%
Case 4 21 (1.45) 10% of controls 29%
Control values (n = 20) 107–145 (129) 8.20–18.50 (14.50) 10%
Case 1 and 2 are two patients from the same family who showed a remarkable clinical response to CoQ supplementation. Cases 3 and 4 present a pathogenic mutation in COQ2 gene.
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Acidic vacuoles were significantly increased in patient fibroblasts 
with respect to controls (Fig. 6B). To confirm the presence of mito-
chondrial degradation or mitophagy in CoQ deficient cells, we 
performed electron microscopy on control and patient fibroblasts. 
Figure 7A–C clearly show the presence of autophagosomes, and 
laminar bodies in patient fibroblasts indicating extensive autophagy. 
In early autophagosomes we can clearly see mitochondria that are 
being degraded. These ultrastructural alterations were markedly 
alleviated by CoQ supplementation. To verify this hypothesis we 
performed a double staining immunofluorescence of cathepsin, a 
lysosomal marker and cytochrome c, a mitochondrial marker. Figure 
8 clearly shows that cathepsin D colocalized with cytochrome c, 
suggesting that mitochondria were being degraded within autopha-
gosomes. Colocalization was addressed in cells in which no sign of 
apoptosis was observed.
Role of CoQ, ROS generation and MPT in autophagy. In order 
to elucidate whether autophagy in CoQ deficient fibroblasts could be 
mitigated by restoring mitochondrial functionality by CoQ supplemen-
tation, we cultured both control and patient fibroblasts in the presence 
of CoQ (100 µM) for 72 hours and analyzed them by β-galactosidase 
staining. As is shown in Figure 9, CoQ supplementation drastically 
reduced the intensity of β-galactosidase staining, indicating a reduction 
in lysosomal activity following CoQ treatment.
To further examine the role of ROS generation in CoQ-deficiency 
induced autophagy, we cultured patient fibroblasts in the presence 
quencher of calcein fluorescence, to selectively label mitochondria. 
In control fibroblasts a distinct mitochondrial label was preserved 
such that it colocalizes with MitoTracker red reagent signal (Fig. 4A). 
Calcein fluorescence was lost in mitochondria presenting MPT in 
CoQ-deficient fibroblasts (Fig. 4A and B). We also confirmed that 
CoQ supplementation significantly reduced the number of fibro-
blasts with MPT (Fig. 4B).
Mitochondrial degradation in CoQ deficiency. Recent evidence 
suggests a possible involvement of ROS and MPT in autophagy.25,26 
In the MPT, the opening of PT pores causes mitochondria to become 
permeable to all solutes up to a molecular mass of about 1500 Da, 
an event leading to the activation of the autophagy machinery. To 
verify the mitochondri l degradation in CoQ deficiency we first 
analyzed the expression of proteins involved in autophagic processes 
such as Atg12, Beclin and LC3. Figure 5A and B show that these 
autophagic proteins (and their corresponding mRNAs) were over-
expressed in patient fibroblasts as compared to control fibroblasts. 
We also investigated the conversion of LC3-I to LC3-II as a marker 
of autophagic activity. We found a significant increase in LC3-II 
conversion in patient extracts indicating enhanced autophagosome 
formation (Fig. 5B). In addition, we found much greater intensity 
of lysosomal indicators such as β-galactosidase, LC3, cathepsin 
D, LysoTracker in CoQ-deficient fibroblasts, suggesting increased 
autophagy in these cells (Fig. 6A). We also quantified levels of acidic 
vacuoles by using Lysotracker staining and flow cytometry analysis. 
Figure 1. Mitochondrial enzyme activities of respiratory chain complexes in human with CoQ deficiency. NADH:coenzyme Q1 oxidoreductase (complex I), 
cytochrome c oxidase (complex IV), ubiquinol:cytochrome c oxidoreductase (complex III), succinate:cytochrome c reductase (complex II + complex III) and 
citrate synthase (CS) were determined as described in Material and Methods. Recovery of enzyme activities in patients fibroblasts under CoQ supplementa-
tion (100 µM) for 72 hours, was also assayed. Results (mean ± SD) are expressed in U/CS (units per citrate synthase). *p < 0.05, **p < 0.01 between 
control and CoQ deficient fibroblasts. ap < 0.05 between the presence and the absence of CoQ.
©2
00
9 
La
nd
es
 B
io
sc
ie
nc
e.
 D
o 
no
t d
ist
rib
ut
e.
Coenzyme Q deficiency and autophagy
22 Autophagy 2009; Vol. 5 Issue 1
we confirmed that both inhibitors effectively inhibited autophagy 
and reduced the β-galactosidase staining of CoQ deficient fibro-
blats (Fig. 10A). We then examined CoQ deficient and control 
fibroblasts for viability and apoptosis. Figure 10 clearly shows that 
inhibiting autophagy in CoQ-deficient fibroblasts significantly 
reduced cell viability and increased the rate of apoptosis. These 
observations strongly suggest that autophagy plays a protective role 
in CoQ-deficient fibroblasts through the recycling/elimination of 
dysfunctional mitochondria (Fig. 10B and C).
CoQ deficiency in Atg5-/- MEFs sensitized to apoptosis. To 
verify the role of autophagy in survival of CoQ deficient cells, apop-
tosis was examined in CoQ deficient wild-type and Atg5-/- MEFs. 
CoQ deficiency was produced in these cells by treatment with 
PABA, a specific inhibitor of CoQ biosynthesis.27 First, we verified 
that PABA treatment indeed induced CoQ deficiency in wild-type 
and knockout fibroblasts (Fig. 11A). In the case of MEFs, we deter-
mined CoQ9, which is the predominant form of coenzyme Q in 
of two antioxidants, BHA and N-acetylcisteine, and examined the 
rate of autophagy. As we have earlier seen for CoQ supplementation, 
both antioxidants significantly attenuated autophagy (Fig. 9).
To confirm a role for the MPT opening in CoQ deficiency-
induced autophagy, we cultured patient fibroblasts in the presence 
of cyclosporine (5 µM), an immunosuppressant which binds to 
cyclophilin D and inhibits MPT pore opening. As is shown in Figure 
9, the inhibition of MPT by cyclosporine decreased autophagy. In 
contrast, tacrolimus (5 µM), an immunosuppressant that does not 
block MPT, had no effect on autophagy (Fig. 9). Together these 
observations suggest that the ROS production and MPT activation 
in CoQ deficient cells may be involved in triggering autophagy.
Physiopathology of autophagy in CoQ deficiency. In order to 
elucidate whether autophagy in CoQ-deficient fibroblasts was a 
protective or pathological mechanism, we examined the effect of 
blocking autophagy using 3-MeA (20 mM) or wortmannin (10 µM), 
well-characterized inhibitors of the early stages of autophagy. First, 
Figure 2. Western blot analysis of mitochondrial proteins in CoQ deficiency. (A) Fibroblast protein extracts (50 µg) were separated on a 12.5% SDS poly-
acrylamide gel and immunostained with antibodies against complex I (39 KDa subunit), complex III (core 1 subunit), and complex IV (subunit II). (B) Recovery 
of complex III expression levels in patient fibroblats under CoQ supplementation (100 µM) for 72 hours. Protein levels were determined by densitometric 
analysis of three different western blots and normalized to GADPH signal. *p < 0.05, **p < 0.01 between control and CoQ deficient fibroblasts. ap < 
0.05 between the presence and the absence of CoQ.
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reduced CoQ-dependent respiratory enzymatic activities 
(Compex III and Complex II + III). Interestingly, Complex 
IV also showed reduced activity, while the activity of 
complex I was not affected. These data correlate with the 
reduced levels of subunits of complex III and IV seen on 
immunoblots, while the levels of complex I subunits were 
not affected. Thus, the expression of proteins of complexes 
III and IV were reduced, while the expression of proteins of 
complex I was not affected. These observations suggest that 
the primary effect of CoQ deficiency might be to affect the 
activity, organization and assembly of complex III as it has 
been reported in yeast,2 with effects on complex IV being 
a secondary consequence. The respiratory chain consists of 
interconnected complex I1-complex III2-complex IV4, and 
III2IV4 supercomplexes in a 2:1 ratio.
28 Therefore, complex 
III disorganization might affect complex IV association 
with complex III in these large supercomplexes,29 thus 
altering complex IV activity and composition.30
Deficient mitochondrial protein expression levels and 
reduced respiratory enzyme activities may impair normal 
mitochondrial electron flow and proton pumping, inducing 
a drop in mitochondrial membrane potential. Our data 
has shown that CoQ-deficient fibroblasts possess reduced 
mitochondrial potential, which may contribute to impaired 
mitochondrial protein import and aggravate mitochondrial 
dysfunction. Similar results in fibroblasts harboring COQ2 
or PDSS2 mutations have been recently shown.19
ROS production and oxidative stress is another 
common consequence of dysfunctional mitochondria. Our 
results show a significant increase in ROS generation in 
CoQ-deficient fibroblasts that was partially mitigated by 
CoQ supplementation. CoQ deficiency does not always 
produce oxidative stress,23,24 and depends on the severity 
of CoQ biosynthetic defect.19 Generated ROS can be 
released into cytosol and trigger “Reactive Oxygen Species 
(ROS)-induced ROS-release” (RIRR) in neighboring 
mitochondria. This mitochondrion-to-mitochondrion 
ROS-signaling constitutes a positive feedback mechanism 
for enhanced ROS production, potentially leading to signif-
icant mitochondrial injury.31 Recent studies by a number of groups 
have demonstrated that ROS can directly modify signaling proteins 
through different modifications, for example by nitrosylation, 
carbonylation, disulphide bond formation and glutathionylation. 
Moreover, redox modification of proteins permits further regulation 
of cell signaling pathways.32 Thus, it has been proposed that ROS 
damage can induce the mitochondrial permeability transition (MPT) 
by opening of nonspecific high conductance permeability transition 
(PT) pores in the mitochondrial inner membrane.25,33,34 This, in 
turn, leads to a simultaneous collapse of mitochondrial membrane 
potential. Our results verify this hypothesis, showing the presence of 
MPT in CoQ deficient fibroblasts. In the MPT, the opening of PT 
pores causes mitochondria to become permeable to all solutes up to a 
molecular mass of about 1500 Da.35,36 After the MPT, mitochondria 
undergo a dramatic swelling driven by colloid osmotic forces, which 
culminates in the rupture of the outer membrane and release of 
proapoptotic mitochondrial intermembrane proteins into the cytosol, 
such as cytochrome c, apoptosis inducing factor, Smac/Diablo and 
mouse cells. We then analyzed cell viability and apoptosis in both 
CoQ-deficient wild-type and knockout fibroblasts. CoQ deficiency 
induced a high viability and low level of apoptosis in wild-type MEFs 
as determined by detecting caspase activation, cytochrome c release, 
and nuclear condensation (Fig. 11B). In contrast, Atg5-/- MEFs 
were significantly more sensitive to CoQ deficiency induction with a 
significant decrease in cell viability and a two-fold increase in apop-
tosis over that in wild-type cells (Fig. 11B). CoQ supplementation of 
PABA-treated MEFs reduced cell death to control values, confirming 
the specificity of apoptotic induction by CoQ deficiency.
Discussion
The molecular basis and pathogenic mechanisms of the various 
primary and secondary forms of CoQ deficiency remain largely 
unknown. In this work, we studied the pathophysiology of CoQ 
deficiency in cultured fibroblasts derived from four patients with 
CoQ deficiency.8,9,18 First, we assessed mitochondrial function in 
cultured fibroblasts. As expected, CoQ-deficient fibroblasts showed 
Figure 3. Mitochondrial dysfunction in CoQ deficiency. (A) Mitochondrial depolariza-
tion in CoQ-deficient fibroblasts. Membrane potential was assessed by flow cytometry 
using MitoTracker Red (Molecular Probes, Eugene, OR). A clear decrease of mitochon-
drial potential was observed in patient fibroblasts. **p < 0.01 between control and 
CoQ-deficient fibroblasts. (B) ROS generation in CoQ deficiency. Cellular generation 
of ROS in fibroblasts from control and patients was determined by flow cytometry using 
dichlorodihydrofluorescein, as described in Materials and Methods. We also tested the 
effect of CoQ supplementation (100 µM) during 72 hours in ROS generation. Results 
are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 
0.01, ***p < 0.001 between control and CoQ deficient fibroblasts. ap < 0.05, bp < 
0.01 between the presence and the absence of CoQ.
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Figure 4. Imaging the Mitochondrial Permeability Transition Pore in control and CoQ deficient fibroblasts. (A) Fibroblasts were loaded with calcein AM, 
which passively diffuses into the cells and accumulates in cytosolic compartments, including mitochondria. The fluorescence from cytosolic calcein was 
quenched by the addition of CoCl2, while the fluorescence from the mitochondrial calcein was maintained in normal mitochondria. Arrows: CoQ deficient 
fibroblasts showing lost of calcein fluorescence, indicating MPT. Bar =15 µm. (B) Quantification of fibroblasts visibly undergoing MPT. **p < 0.01 between 
control and CoQ deficient fibroblasts. ap < 0.05, between the presence and the absence of CoQ.
others. Cyclosporin A (CsA), and various of its analogs inhibit the 
MPT through interaction with cyclophilin D (CypD).37 PT pores 
are composed of the voltage-dependent anion channel (VDAC) in 
the outer membrane, the adenine nucleotide translocator (ANT) in 
the inner membrane and CypD in the matrix space.38 It has been 
reported that ROS can promote MPT by causing oxidation of thiol 
groups on the adenine nucleotide translocase (ANT), which forms 
part of the MPT pore.39 Moreover, a possible involvement of the 
MPT in the induction of autophagy of altered mitochondria it has 
been postulated.25,31,34 Therefore, oxidative stress in CoQ-deficient 
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promote cell injury.41 Appropriate regula-
tion of autophagy is thus  essential for cellular 
homeostasis. The molecular mechanism 
underlying autophagy has been extensively 
researched in the past decade, and the 
genes participating in this process, denoted 
ATGs,42 were found to be conserved in 
yeast and humans.43,44 In CoQ-deficient 
fibroblasts, we demonstrated here increased 
expression of autophagic genes and proteins 
suggesting the activation of the autophagic 
machinery in these patients. Moreover, lyso-
somal/autophagic markers (β-galactosidase, 
LC3, cathepsin, LysoTracker) were enhanced 
in CoQ-deficient fibroblasts indicating lyso-
somal proliferation. Such findings led to the 
assumption that autophagy was activated in 
CoQ-deficient fibroblasts. We confirmed 
these results by electron microscopy that 
clearly showed the presence of laminar 
bodies and autophagosomes engulfing mito-
chondria. Immunofluorescence studies also 
verified that typical lysosomal enzymes, 
such as cathepsin D, colocalized with a 
mitochondrial marker, such as cytochrome 
c. These results suggest that autophagy in 
CoQ-deficient fibroblasts is characterized 
by a selective degradation of dysfunctional 
mitochondria or mitophagy.
But are ROS and MPT essential for 
autophagy in CoQ deficiency? To address 
this question, we tested the effect of 
N-acetyl-cysteine (NAC), and BHA, two 
general antioxidants, and the MPT-inhibitor 
cyclosporin on the formation of autopha-
gosomes in CoQ-deficient fibroblasts using 
β-galactosidase as a marker. Results showed 
that both antioxidants and MPT inhibitors reduced β-galactosidase 
staining. These data suggest that ROS generation and MPT are 
involved in CoQ deficiency-induced autophagy. Increasing evidence 
corroborates the fact that autophagy of mitochondria may occur 
selectively. For example in yeast, the mitochondrial proteins Uth1p 
and Aup1, are required for efficient mitochondrial autophagy, but 
corresponding mammalian proteins have yet to be identified.45,46 
Moreover, recent studies report that ROS plays a key role in selenite-
induced mitochondrial damage and mitophagy.47,48 Our work also 
strongly indicates that ROS/MPT induced autophagy can show 
selectivity for mitochondria in CoQ deficiency.
There is a controversy to consider if autophagy promotes or 
prevents cell death.41,49,50 If autophagy removes damaged mito-
chondria that would otherwise activate caspases and apoptosis, then 
autophagy could be protective. In agreement with this hypoth-
esis, we demonstrated that disruption of autophagic processing 
in CoQ-deficient fibroblasts by 3-MA or wortmannin promoted 
caspase-dependent cell death. To verify this hypothesis, we examined 
the effects of CoQ deficiency in a well-established genetic knock-out 
of autophagy, Atg5-/- mouse embryonic fibroblasts (MEFs).19,20 The 
fibroblasts might cause mitochondrial damage, MPT activation and 
mitochondrial dysfunction. Elimination of these dysfunctional mito-
chondria would be critical to protect cells from the damage of altered 
mitochondrial function and release of potentially proapoptotic 
molecules. Mitochondrial turnover is predominantly autophagic 
sequestration and delivery to lysosomes for hydrolytic degrada-
tion, a process also called mitophagy. Our data suggests mitophagy 
could take place as a process that specifically targets dysfunctional 
mitochondria in CoQ deficient fibroblasts. We postulate that 
the structural composition of mitochondria might be affected by 
increased ROS production, which in turn determines their self-elim-
ination. An example could be the presence of oxidized mitochondrial 
unsaturated fatty acids and/or proteins.
Autophagy is a process by which cytosol and organelles are seques-
tered within double-membrane vesicles that deliver the contents to 
the lysosome/vacuole for degradation and recycling of the resulting 
macromolecules.40 Autophagy is typically activated by fasting and 
nutrient deprivation. During fasting, autophagy is important for 
generating amino acids and metabolic intermediates to maintain 
ATP production. Both insufficient and excess autophagy can 
Figure 5. Autophagic transcripts and protein expression. (A) Expression of ATG12, Beclin, and LC3 
transcripts in control and patient fibroblasts were assessed by Real Time PCR as described in Material 
and Methods. (B) Protein expression of Atg12 and LC3 was performed by Western blotting as described 
in Material and Methods. *p < 0.05, **p < 0.01 between control and CoQ-deficient fibroblasts.
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II), cytochrome c oxidase (complex IV), ubiquinol:cytochrome c 
oxidoreductase (complex III), succinate:cytochrome c reductase 
(complex II + complex III) and citrate synthase (CS) were deter-
mined in cell extracts using previously described spectrophotometric 
Methods.8,54 Results are expressed as Units/CS (mean ± SD). 
Proteins of fibroblasts homogenates were analyzed by the Lowry 
procedure.55
CoQ determination. Cell samples were lysed with 1% SDS and 
vortexed for 1 min. A mixture of ethanol:isopropanol (95:5) was 
added and the samples were vortexed for 1 min. To recover CoQ, 5 
absence of autophagy in Atg5-/- cells sensitized them to apoptosis 
when coenzyme Q deficiency was induced by treatment with a 
specific inhibitor of CoQ biosynthesis (PABA). All together, these 
findings indicate that inhibition of autophagy in CoQ deficiency 
can promote cell death, suggesting the protective role of autophagy 
in this disease.
Material and Methods
Reagents. Monoclonal Anti-Actin antibody, butylated hydroxyani-
sole (BHA), N-acetylcisteine, 3-methyl adenine (3MeA), propidium 
iodide (PI), 4-aminobenzoate (4AB), and trypsin were purchased from 
Sigma Chemical Co., (St. Louis, Missouri). Monoclonal Antibodies 
specific for oxidative phosphorylation (Anti-human Complex I 
(NADH-ubiquinol Oxidoreductase, 39 kDa subunit), Complex 
III (ubiquinol-cytochrome c oxidoreductase, Core 1 subunit) and 
Complex IV (cytochrome c oxidase; COX II), Carboxy-2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA), and Hoechst 
3342, were purchased from Invitrogen/Molecular Probes (Eugene, 
Oregon). Cyclosporine A was acquired from Fluka BioChemika 
(Buchs SG, Switzerland). Anti-cytochrome c antiobodies were 
purchased from PharMingen (BD Bioscience, San Jose, California). 
Anti-GAPDH monoclonal antibody, clone 6C5, was purchased from 
Research Diagnostic, Inc., (Flanders, New Jersey). Anti-hAtg12 was 
acquired from Biosensis (South Australia, Australia). Anti-MAP LC3 
(N-20) and Anti-Cathepsin D were purchased from Santa Cruz 
Biotechnology (Santa Cruz, California).
Anti-active caspase-3 was obtained from Cell Signalling Technology 
(Beverly, Massachusetts). A cocktail of protease inhibitors (complete 
cocktail) was purchased from Boehringer Mannheim (Indianapolis, 
Indiana). The Immun Star HRP substrate kit was from Bio-Rad 
Laboratories Inc., (Hercules, California).
Fibroblasts cultures. Cultured fibroblasts were derived from four 
patients with a CoQ deficiency. Cases 1 and 2 are patients from the 
same family (daughter and father) with a remarkable clinical response 
to CoQ supplementation.18 Cases 3 and 4 presented a pathogenic 
mutation in the COQ2 gene;8,51 Control fibroblasts were human 
primary fibroblasts from healthy volunteers. Mouse embryonic fibro-
blasts (MEFs) derived from wild-type and Atg5-/- mouse embryos 
were a kind gift of Noboru Mizushima, Tokyo Medical and Dental 
University, Japan.52,53 Ethical issues: The study was approved by the 
Ethical Committee of the Hospital San Joan de Deu, and samples 
from patients and controls were obtained according to the Helsinki 
Declarations of 1964, as revised in 2001.
Fibroblasts from CoQ deficient patients and controls were 
cultured at 37°C using DMEM 4.5 g/L Glucose, L-Glutamine, 
Pyruvate (Invitrogen, Prat de Llobregat, Barcelona) supplemented 
with an antibiotic/antimycotic solution (Sigma Chemical Co., St. 
Louis, Missouri) and 20% fetal bovine serum (FBS, Linus). When 
required, supplemental CoQ pre-diluted in FBS was added to the 
plates at a final concentration of 100 µM (Coenzyme Q10, Synthetic 
Minimun 98%, HPLC, Sigma).
Fibroblasts growth rate. Two hundred thousand fibroblasts 
were cultured in the absence or presence of CoQ (100 µM), for 
72 h. After removing the supernatant along with any dead cells, 
cell counting was performed from three high power fields with an 
inverted microscope and a 40X objective.
Mitochondrial enzyme activities. Activities of NADH:coenzyme 
Q1 oxidoreductase (complex I), succinate deshydrogenase (complex 
Figure 6. Autophagic markers in CoQ deficient fibroblasts. (A) Representative 
images of autophagic markers (Lysotracker, ATG12, LC3, cathepsin D) in 
control and patients’ fibroblasts that were visualized by immunofluorescence, 
as described in Material and Methods. β-galactosidase staining was exam-
ined by light microscopy as described in Material and Methods. Bar = 15 
µm. (B) Quantification of acidic vacuoles in control and patient fibroblast by 
Lysotracker staining and flow cytometry analysis.*p < 0.01 between control 
and CoQ-deficient fibroblasts.
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ml/min and a mobile phase containing 65:35 methanol/n-propanol 
and 1.42 mM lithium perchlorate. CoQ levels were analyzed with 
ultraviolet (System Gold 168), electrochemical (Coulochem III ESA) 
or radioactivity (Radioflow Detector LB 509, Berthod Technologies) 
based detectors as necessary. Coenzyme Q9 (CoQ9) was used as 
internal standard. In the case of MEFs, CoQ9 levels were analyzed 
using CoQ6 as internal standard. CoQ content was determined as 
nmol/g protein.
ml of hexane was added and the samples were centrifuged at 1000 
xg for 5 min at 4°C. The upper phases from three extractions were 
recovered and dried using a rotary evaporator. Lipid extracts were 
suspended in 1 ml of ethanol, dried in a speed-vac and stored at 
-20°C. Samples were suspended in the suitable volume of ethanol 
prior to HPLC injection. Lipid components were separated by a 
Beckmann 166–126 HPLC system equipped with a 15-cm Kromasil 
C-18 column in a column oven set to 40°C, with a flow rate of 1 
Figure 7. Ultrastructure of CoQ-deficient fibroblasts. (A) Control fibroblasts are showing mitochondria with typical ultrastructure. Bar = 1 µm. Laminar bodies 
and autophagosome with mitochondria were present in CoQ-deficient fibroblast (case 1 and 4); Bar = 0.5 µm. Mitochondria of fibroblasts from patients 
supplemented with CoQ (100 µm) for 72 h. Bar = 1µm. (B) Control (Bar = 1 µm) and case 4 (Bar = 2 µm) fibroblasts at low magnification. (C) Case 1 and 
4 fibroblasts at high magnification (Bar = 0.5 µm).
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GGG GAA GG 3' (Forward primer) and 5' GGT TCG TGT TCG 
CTC TAC TGC 3' (Reverse primer) amplify a sequence of 198 
nucleotides. Human MAP-LC3 primers 5'-GCC TTC TTC CTG 
CTG GTG AAC-3' (Forward primer) and 5'-AGC CGT CCT 
CGT CTT TCT CC-3' (Reverse primer) amplify a sequence of 91 
nucleotides. Actin was used as a housekeeping control gene.
Mitochondrial permeability transition (MPT). MPT was evalu-
ated using the the MitoProbe Transition Pore Assay Kit (Invitrogen/
Molecular Probes). Cells are loaded with calcein-AM, which passively 
diffuses into the cells and accumulates in cytosolic compartments, 
including the mitochondria. Once inside cells, calcein AM is cleaved 
by intracellular esterases to liberate calcein (a very polar fluorescent 
dye), which does not cross the mitochondrial or plasma membranes 
in appreciable amounts over relatively short periods of time. The 
fluorescence from cytosolic calcein can be quenched by the addition 
of cobalt (CoCl2), while the fluorescence from the mitochondrial 
calcein is maintained in normal conditions. Activation and inhibi-
tion of MPT pore formation in control and patient fibroblasts in 
vivo were visualized through simultaneous loading with calcein AM 
and MitoTracker Red dyes. Green calcein fluorescence is visible 
throughout the cell; orange fluorescence indicates the colocaliza-
tion of calcein and MitoTracker Red indicators. Presence of MPT 
allows cobalt to enter the mitochondria, which quenches the calcein 
fluorescence but leaves the red fluorescence of the MitoTracker Red 
dye unaffected. Residual calcein fluorescence would be expected in 
mitochondria where the MPT had not occurred.
Immunofluorescence microscopy. Fibroblasts were grown on 
1mm width (Goldseal No. 1) glass coverslips for 24–48 h in DMEM 
containing 20% FBS. Cells were rinsed once with PBS, fixed 
in 3.8% paraformaldehyde for 5 min at room temperature, and 
CoQ biosynthesis rate. The CoQ biosynthesis rate 
in these cells was determined by the incorporation of 
the radiolabelled p-hydroxybenzoic acid ([14C]-pHB), 
a precursor of the quinone ring of CoQ, in the pres-
ence of 100-fold excess of non radiolabeled pHB.18 
CoQ synthesized by cells was extracted and analyzed 
with a radioflow detector after HPLC separation as 
described previously. Results are expressed as cpm x 
106/mg protein.
Measurement of intracellular generation of ROS. 
Flow-cytometric analysis of the intracellular generation 
of ROS was performed using dichlorodihydrofluores-
cein, as well as dihydrorhodamine 123, as a probe. 
Cells were cultured in six-well plates (35 mm diameter 
well) and, at confluence, incubated with dichlorodi-
hydrofluorescein (1 µM) or dihydrorhodamine 123 
(1 µM) for 30 min. at 37°C. Once the incubation was 
finished, cells were harvested, washed, centrifuged, 
resuspended in D-MEM medium and analyzed by 
flow cytometry.
Mitochondrial membrane potential (ΔΨm). Cells 
were cultured in six-well 35 mm plates, and at conflu-
ence, cells were incubated for 30 min with 100 nM 
Mitotracker (Mitotracker Red CMXRos, Molecular 
Probes). Cells were subsequently harvested, washed 
with fresh medium, washed, centrifuged (500 xg), 
resuspended in RPMI medium and analyzed by flow 
cytometry.
Immunoblotting. Western blotting was performed using stan-
dard methods. After protein transfer, the membrane was incubated 
with various primary antibodies diluted 1:1000, and then with the 
corresponding secondary antibody coupled to horseradish peroxidase 
at a 1:10000 dilution. Specific protein complexes were identified 
using the Immun Star HRP substrate kit (Biorad Laboratories Inc., 
Hercules, California).
β-galactosidase test.56 Cultured cells were washed in PBS (pH 
7.4), fixed with 3.7% formaldehyde, and incubated overnight 
at 37°C in freshly prepared staining buffer [1 mg mL-1 X-gal 
(5-bromo-4-chloro-3-indolyl β-D-galactoside), 5 mM K3Fe[CN]6, 
5 mM K4Fe [CN]6, and 2 mM MgCl2 in PBS, pH 6.0, or in citrate-
buffered saline, pH 4.5]. At the end of the incubation, cells were 
washed with PBS, examined and photographed using a Leica CTR 
5000 microscope. β-galactosidase staining was quantified using 
ImageJ software.
Loading of lysotracker red. LysoTracker (100 nM) was added to 
cultured fibroblasts. After 30 min, each well was washed two times 
with fresh DMEM, and fixed with 2% paraformaldehyde in PBS 
for 10 min at 4°C. The red fluorescence of LysoTracker was visual-
ized and measured using a DeltaVision system (Applied Precision; 
Issaquah, Washington) with an Olympus IX-71 microscope.
Real time PCR. The fibroblast expression of Atg12, MAP-LC3, 
and Beclin1 genes in fibroblasts was analyzed by SYBR Green quan-
titative PCR using mRNA extracts and primers hCOQ-RQ-F and 
hCOQ-RQ-R. Real Time Beclin 1 primers 5'-GGA TGG ATG 
TGG AGA AAG GCA AG-3' (Forward primer) and 5'-TGA GGA 
CAC CCA AGC AAG ACC-3' (Reverse primer) amplify a sequence 
of 152 nucleotides. Human Atg12 primers 5' ATT GCT GCT GGA 
Figure 8. Mitochondrial degradation during autophagy. Cultured fibroblasts from case 4 
were cultured in the presence or absence of CoQ (100 µM) for 72 hours. Then, cells were 
harvested, fixed, and immunostained with anticathepsin (lysosomal marker) and cytochrome 
c (mitochondrial marker) and examined in a fluorescence microscope as described in 
Material and Methods. Colocalization of both markers was assessed by the DeltaVision 
software. Bar = 5 µm.
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California) and analyzed using an upright fluorescence microscope 
(Leica DMRE, Leica Microsystems GmbH, Wetzlar, Germany). 
Deconvolution studies and 3D projections were performed using 
a DeltaVision system (Applied Precision; Issaquah, Washington) 
with an Olympus IX-71 microscope. The deconvolved images were 
derived from optical sections taken at 30-nm intervals using a 60x 
PLAPON objective with a 1.42 numerical aperture.
Electron microscopy. Fibroblasts were fixed for 15 min in the 
culture plates with 2% glutaraldehyde in culture medium, then 
for 30 min in 2% glutaraldehyde-0.1 M NaCacodylate/HCl, pH 
7.4. They were then washed three times in 0.2 M NaCacodylate/
HCl, pH 7.4 for 10 min and then post-fixed with 1% OsO4-0.15 
permeabilized in 0.1% saponin for 5 min. For immunostaining, glass 
coverslips were incubated with primary antibodies diluted 1:100 in 
PBS, and were incubated 1–2 h at 37°C in a humidified chamber. 
Unbound antibodies were removed by washing the coverslips with 
PBS (three times, 5 min). The secondary antibody, a FITC-labeled 
goat antimouse antibody or a tetramethyl rhodamine goat antirabbit 
(Molecular Probes), diluted 1:100 in PBS, were added and incu-
bated for 1 h 37°C. Coverslips were then rinsed with PBS for 3 min, 
incubated for 1 min with PBS containing Hoechst 33342 (1 µg/
ml) or TOPRO (1 µM) and washed with PBS (three 5 min washes). 
Finally, the coverslips were mounted onto microscope slides using 
Vectashield Mounting Medium (Vector Laboratories, Burlingame, 
Figure 9. Role of ROS and MPT in CoQ deficiency mitophagy. β-galactosidase staining was performed on cultured fibroblasts from control and patients (case 
1 and 4) treated with two antioxidants BHA (40 µM), and N-acetylcisteine (10 mM), and an inhibitor of MPT, cyclosporine (5 µM). Tacrolimus (5 µM), an 
immunosuppressant which has no effect in MPT, was used a negative control. As positive control we treated fibroblasts with CoQ (100 µM), which restores 
the deficiency and reduces β-galactosidase staining. β-galactosidase staining was quantified using the ImageJ software. Results are expressed as mean ± 
SD of three independent experiments. *p < 0.05 between control and patients cells. ap < 0.05 between the presence and the absence of the drugs.
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analyzed using Student t-test for comparing two groups and ANOVA 
for more than two groups. The level of significance was set at p 
< 0.05.
Conclusion
In normal physiology, cells utilize autophagy to eliminate 
damaged, dysfunctional, and superfluous cytoplasmic components 
to maintain cellular homeostasis and adjust to changing physi-
ological demands. In this respect, mitochondrial degradation by 
autophagy (mitophagy) may play an essential role in maintaining 
cellular homeostasis in CoQ deficiency. We suggest that autophagy 
is triggered in our model as a “stress-induced” mechanism involved in 
the degradation of dysfunctional CoQ-deficient mitochondria. This 
work is the first direct demonstration of the role of autophagy in the 
pathophysiology of CoQ deficiency.
M NaCacodylate/HCl, pH 7.4 for 30 min. After dehydration in 
increasing concentrations of ethanol, 5 min for each step: 30, 50, 
70 and 95%, impregnation steps and inclusion were performed in 
Epon and finally polymerized at 60°C for 48 h. 60–80 nm sections 
were obtained using an ultramicrotome RMC-MTX (Tucson, 
Arizona), and contrasted with uranyl acetate and lead citrate. 
Observations were performed on a Philips CM-10 transmission 
electron microscope.
Analysis of apoptosis and viable cells. Apoptosis was assessed by 
observing nuclei fragmentation by Hoechst staining, cytochrome c 
release, and caspase 3 activation. Viable cells were determined from 
their normal nuclear morphology and exclusion of propidium iodide. 
In each case 10 random fields and more of 500 cells were counted.
Statistical analysis. All results are expressed as mean ± SD of 
three independent experiments. The measurements were statistically 
Figure 10. Autophagy is required for optimal survival of CoQ deficient fibroblasts. Control and CoQ-deficient fibroblasts (case 4) were treated for 48 
hours with 3-MA (20 mM) or wortmannin (10 µM), and we determined β-galactosidase staining (A), cell viability (B), and the rate of apoptotic cells (C) as 
described in Material and Methods. Results are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01 between control and 
CoQ-deficient fibroblasts.
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